yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34587751-853DC543-D66F-40F6-A0E9-FC0F2E5E319E
Q34587751-853DC543-D66F-40F6-A0E9-FC0F2E5E319E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34587751-853DC543-D66F-40F6-A0E9-FC0F2E5E319E
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
P2093
Q34587751-853DC543-D66F-40F6-A0E9-FC0F2E5E319E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34587751-853DC543-D66F-40F6-A0E9-FC0F2E5E319E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
76084e28e6601ade5f214be98bea630af462fcad
P1545
6
http://www.w3.org/2001/XMLSchema#string
P2093
Robert S Benjamin
http://www.w3.org/2001/XMLSchema#string